Hypertriglyceridaemia [fndg]
Relevance [qlco]
treatment [ftcn]
Options [ftcn]
Focus [spco]
cerivastatin [orch, phsu]
Triglyceride level [lbtr]
Several [qnco]
Lipid [lipd]
Parameters [fndg]
Aid [socb]
Prediction [idcn]
Coronary heart disease risk [inpr]
Elevated [qlco]
Plasma triglyceride level [lbpr]
Increased [qnco]
coronary heart disease [dsyn]
Hypertriglyceridaemia [fndg]
Second [qnco]
Dyslipidaemia [dsyn]
Abnormality [fndg]
hypertensive [fndg]
Subject [grup]
Increased [qnco]
Low Density Lipoprotein Cholesterol [bacs, strd]
Defined [cnce]
national [inpr]
Cholesterol [bacs, strd]
educational program [edac]
Fasting [fndg]
Triglyceride level [lbtr]
mmol/L [qnco]
mg dl [qnco]
Primary Indicator [qlco]
treatment [ftcn]
Dyslipidaemia [dsyn]
Raised [qnco]
Triglyceride level [lbtr]
Present [qnco]
At risk [qlco]
coronary heart disease [dsyn]
Total Cholesterol [lbpr]
Normal [qlco]
Raised [qnco]
Triglyceride level [lbtr]
Increased [qnco]
coronary heart disease [dsyn]
Diet [food]
Age [orga]
Life Style [socb]
Range [qnco]
Medical [ftcn]
condition [dsyn]
Drug Therapy [topp]
Metabolic Disorders [dsyn]
Affect [menp]
Triglyceride level [lbtr]
coronary heart disease [dsyn]
risk factors [qnco]
Present [qnco]
Triglyceride [bacs, lipd]
Reducing [qlco]
therapy [ftcn]
Improved [qlco]
Needed [qlco]
Independent [idcn]
Triglyceride [bacs, lipd]
reduction [npop]
Lipid [lipd]
Profile [lbpr]
Patients [podg]
Trial [resa]
Required [ftcn]
Quantify [qnco]
Benefits [qnco]
lowering [spco]
Triglyceride [bacs, lipd]
Target [ftcn]
Target [ftcn]
Defined [cnce]
national [inpr]
Cholesterol [bacs, strd]
educational program [edac]
Ii [aapp]
Table [mnob]
Triglyceride [bacs, lipd]
coronary heart disease [dsyn]
pathogenesis [ftcn]
Thought [menp]
Several [qnco]
Direct [qlco]
Indirect [qlco]
Mechanisms [ftcn]
effects [qlco]
Metabolism [orgf]
Lipoproteins [aapp, bacs]
Transport Proteins [aapp, bacs]
Enzymes [enzy, orch]
Coagulation [ortf]
endothelial dysfunction [dsyn]
Required [ftcn]
Triglyceride [bacs, lipd]
risk factors [qnco]
Mechanism [ftcn]
Direct [qlco]
Atherogenesis [patf]
Process [bpoc]
Patients [podg]
Hypertriglyceridaemia [fndg]
Well [qlco]
dietary control [topp]
Lipid lowering drug [phsu]
Known [qlco]
Statins [orch, phsu]
Fibrates [orch, phsu]
Nicotinic Acids [orch, phsu, vita]
Retrospective Studies [resa]
Real [qlco]
Life [idcn]
Patients [podg]
Receive [qlco]
Form [qlco]
Lipid-lowering therapy [topp]
national level [spco]
cholesterol ldl [bacs, strd]
Education [edac]
Program [cnce]
Defined [cnce]
Target [ftcn]
Need [qlco]
aggressive [mobd]
treatment [ftcn]
Patients [podg]
Statins [orch, phsu]
cerivastatin [orch, phsu]
atorvastatin [orch, phsu]
Efficacy [qlco]
Reducing [qlco]
Triglyceride [bacs, lipd]
Compared [acty]
Old [tmco]
Statins [orch, phsu]
national level [spco]
Cholesterol [bacs, strd]
Education [edac]
Program [cnce]
Target [ftcn]
Lipid [lipd]
Cardiovascular disease [dsyn]
Dyslipidaemia [dsyn]
Including [ftcn]
High Risk [qlco]
Group [idcn]
With [qlco]
Additional [ftcn]
risk factors [qnco]
Exist [cnce]
Heart disease [dsyn]
Diabetes Mellitus [dsyn]
Metabolic syndrome [dsyn]
Late [tmco]
Clinical Studies [resa]
investigating [ftcn]
combination therapies [topp]
i e [diap, inpr]
Dual [inpr]
therapy [ftcn]
Statin [orch, phsu]
effective [qlco]
Lipid [lipd]
Parameters [fndg]
Reducing [qlco]
coronary [bpoc]
Events [evnt]
Clear [qlco]
ONGOING [idcn]
End Point [qlco]
Clinical Studies [resa]
Information [idcn]
Area [geoa]
Consequence [ftcn]
reviews [inpr]
Primary Care [hlca]
Management [ocac]
Policies [inpr]
Dyslipidaemia [dsyn]
Statin [orch, phsu]
Reliability [qnco]
Option [ftcn]
primary treatment [topp]
Care [acty]
Dyslipidaemia [dsyn]
Including [ftcn]
Hypertriglyceridaemia [fndg]
